deCODE Cancer

deCODE Thyroid Cancer test

Two SNPs identify 10% of people of European ancestry who are at 40-150% above average risk of developing thyroid cancer.

The deCODE Cancer Scan detects the same risk factors and markers included in our individual tests for:

Breast Cancer (deCODE BreastCancer™) and
Prostate Cancer (deCODE ProstateCancer™)

together with:

Basal Cell Carcinoma, Bladder Cancer, Colorectal Cancer, Lung Cancer, Ovarian Cancer, Testicular Cancer and Thyroid Cancer.

---

Thyroid Cancer

Screening and prevention

How the deCODE Thyroid Cancer test can help.

The American Cancer Society recommends blood tests or thyroid ultrasound for detection of changes in the thyroid only when there is an indication, such as family history, that a patient may be at increased risk for thyroid cancer.

Having as a complete picture as possible of individual risk, including genetic risk, is always an important starting point for considering screening and intervention options. If thyroid cancer is detected and treated early, the prognosis for patients is very good.

The risk identified by the test is independent and in addition to any other risk the patient may have, including family history.

deCODE Cancer detects two SNPs associated with risk of developing either papillary or follicular cancer of the thyroid gland.

The SNPs are located near two candidate genes, FOXE1 (TTF2) and NKX2-1 (TTF1), on chromosomes 9q22.33 and 14q13.3, respectively.

To date, these markers have been replicated and validated only in populations of European descent.

This content was last reviewed on February 04, 2011.